Ervin Veszprémi

No open positions remaining

67 year

Health Technology

Finance

Consumer Services

Profile

Ervin Veszprémi formerly worked at Medichem SA, as Chief Executive Officer from 2003 to 2014, Invent Invest Holding SL, as Chief Executive Officer from 2015 to 2016, Genmedica Therapeutics SL, as Chairman, Kindred Biosciences, Inc., as Independent Director from 2013 to 2021, Amersham Corp., as Head-Business Unit, Novartis Groupe France SA, as Vice President, Novartis Animal Health US, Inc., as Vice President & Global Head-Marketing in 2002, and Pharmacia Spain SA, as Head-Business Unit.
Mr. Veszprémi received his undergraduate degree from the University of British Columbia.

Former positions of Ervin Veszprémi

Companies	Position	End
KINDRED BIOSCIENCES, INC.	Director/Board Member	27/08/2021
Invent Invest Holding SL Invent Invest Holding SL Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals	Chief Executive Officer	04/10/2016
Medichem SA Medichem SA Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical ingredients	Chief Executive Officer	01/01/2014
Novartis Groupe France SAS Novartis Groupe France SAS Financial ConglomeratesFinance Functions as an investment holding company	Corporate Officer/Principal	-
Novartis Animal Health US, Inc. Novartis Animal Health US, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for animals	Sales & Marketing	01/01/2002

See the detail of Ervin Veszprémi's experience

Training of Ervin Veszprémi

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ervin Veszprémi's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	9
Amersham Corp. Amersham Corp. Investment ManagersFinance Amersham Corp. focuses on the acquisition and ownership of mid-sized manufactures of precision engineered components and assemblies with particular interest in aerospace, automotive and medical device manufacturers and suppliers. The firm invests in small to medium sized companies with annual sales of $10 million to $200 million	Finance
Kindred Biosciences, Inc. Kindred Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for animals	Health Technology
University of British Columbia University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Novartis Groupe France SAS Novartis Groupe France SAS Financial ConglomeratesFinance Functions as an investment holding company	Finance
Genmedica Therapeutics SL Genmedica Therapeutics SL BiotechnologyHealth Technology Engages in the research and development of treatments for metabolic disorders	Health Technology
Novartis Animal Health US, Inc. Novartis Animal Health US, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for animals	Health Technology
Medichem SA Medichem SA Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical ingredients	Health Technology
Pharmacia Spain SA
Invent Invest Holding SL Invent Invest Holding SL Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals	Health Technology